Bokyung Min

481 total citations
18 papers, 385 citations indexed

About

Bokyung Min is a scholar working on Immunology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bokyung Min has authored 18 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bokyung Min's work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Bokyung Min is often cited by papers focused on Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (7 papers) and T-cell and B-cell Immunology (4 papers). Bokyung Min collaborates with scholars based in South Korea and United States. Bokyung Min's co-authors include Yu Kyeong Hwang, Jung Hyun Her, Tae Min Kim, Dae Seog Heo, Hana Choi, C Michael White, Eui‐Cheol Shin, Jeffrey Kluger, Mi-Young Jung and Bhumsuk Keam and has published in prestigious journals such as PLoS ONE, Cancers and Cellular and Molecular Immunology.

In The Last Decade

Bokyung Min

18 papers receiving 373 citations

Peers

Countries citing papers authored by Bokyung Min

Since Specialization

Citations

This map shows the geographic impact of Bokyung Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bokyung Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bokyung Min more than expected).

Fields of papers citing papers by Bokyung Min

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bokyung Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bokyung Min. The network helps show where Bokyung Min may publish in the future.

Co-authorship network of co-authors of Bokyung Min

This figure shows the co-authorship network connecting the top 25 collaborators of Bokyung Min. A scholar is included among the top collaborators of Bokyung Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bokyung Min. Bokyung Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	306 Evaluation of AB-101, an allogeneic cord blood-derived natural killer (NK) cell therapy, as an ADCC enhancer in hematologic and solid tumors 2022 ·Regular and Young Investigator Award Abstracts ·Paul Rogers, (unknown), Hyojin Kim, (unknown), Sunglim Cho, (unknown), (unknown), Lavakumar Karyampudi, (unknown), Peter Flynn, Bokyung Min, Heather K. Raymon	1
2	Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity 2021 ·Cellular and Molecular Immunology ·Bokyung Min, (unknown), You‐Sun Kim, (unknown), (unknown), Hyojin Kim, Eun‐Ji Kim, Yu Kyeong Hwang, Eui‐Cheol Shin, Sungyoo Cho	7
3	129 Development of AB-201, a novel allogeneic anti-HER2-specific CAR-NK cell therapy for the treatment of HER2+ tumors 2021 ·Regular and Young Investigator Award Abstracts ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eun Ji Kim, Eunsol Lee, Jeong‐Min Kim, (unknown), Bokyung Min, (unknown), (unknown), (unknown), Srinivas S. Somanchi, (unknown), Jason B. Litten, Peter Flynn, Heather K. Raymon, Yu Kyeong Hwang	1
4	Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability 2019 ·Cancers ·Eonju Oh, Bokyung Min, Yan Li, (unknown), JinWoo Hong, (unknown), (unknown), Sung June Cho, Yu Kyeong Hwang, Chae‐Ok Yun	13
5	Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy 2018 ·Immune Network ·Bokyung Min, Hana Choi, Jung Hyun Her, Mi Young Jung, Hyojin Kim, Mi-Young Jung, (unknown), (unknown), Yu Kyeong Hwang, Eui‐Cheol Shin	42
6	Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors 2016 ·Cancer Immunology Research ·Yaewon Yang, (unknown), Tae Min Kim, Yong‐Oon Ahn, Hana Choi, (unknown), Bokyung Min, Jung Hyun Her, (unknown), Bhumsuk Keam, Se‐Hoon Lee, Dong‐Wan Kim, Yu Kyeong Hwang, Dae Seog Heo	128
7	Ex-Vivo Expansion of NK Cells From Umbilical Cord Blood Mononuclear Cells for Anticancer Therapy Using the Lymphoma Cell Line 2016 ·Cytotherapy ·H. Chung, (unknown), Hang‐Rae Kim, (unknown), Bokyung Min, Yu Kyeong Hwang	1
8	GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo 2013 ·PLoS ONE ·(unknown), Yuna Lee, (unknown), Jung Hyun Her, (unknown), Mi-Young Jung, Bokyung Min, (unknown), Tae Min Kim, Dae Seog Heo, Yu Kyeong Hwang, Eui‐Cheol Shin	57
9	Effects of Vitamin D on Blood Pressure and Endothelial Function 2013 ·Korean Journal of Physiology and Pharmacology ·Bokyung Min	30
10	Effects of Chimeric Decoy Oligodeoxynucleotide in the Regulation of Transcription Factors NF‐κB and Sp1 in an Animal Model of Atherosclerosis 2012 ·Basic & Clinical Pharmacology & Toxicology ·Woo‐Ram Lee, (unknown), Hyun‐Jin An, (unknown), Kee‐Sik Kim, (unknown), Bokyung Min, Kwan‐Kyu Park	24
11	Apamin inhibits THP-1-derived macrophage apoptosis via mitochondria-related apoptotic pathway 2012 ·Experimental and Molecular Pathology ·Soo-Jung Kim, Jihyun Park, Kyung Hyun Kim, Woo‐Ram Lee, Hyun‐Jin An, Bokyung Min, Sang‐Mi Han, Kee‐Sik Kim, Kwan‐Kyu Park	26
12	A Review of Critical Differences among Loop, Thiazide, and Thiazide-Like Diuretics 2009 ·Hospital Pharmacy ·Bokyung Min, C Michael White	1
13	Electrocardiographic and Blood Pressure Effects of the Ephedra‐Containing TrimSpa Thermogenic Herbal Compound in Healthy Volunteers 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Michael F. Caron, David D. Dore, Bokyung Min, Jeffrey Kluger, (unknown), C Michael White	4
14	An Evaluation of the Impact of Oral Magnesium Lactate on the Corrected QT Interval of Patients Receiving Sotalol or Dofetilide to Prevent Atrial or Ventricular Tachyarrhythmia Recurrence 2006 ·Annals of Noninvasive Electrocardiology ·Brian F. McBride, Bokyung Min, Jeffrey Kluger, (unknown), Nickole N. Henyan, Craig I Coleman, Burton B. Silver, C Michael White	19
15	Absence of QTc‐Interval–Prolonging or Hemodynamic Effects of a Single Dose of Bitter‐Orange Extract in Healthy Subjects 2005 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Bokyung Min, Deborah Cios, Jeffrey Kluger, C Michael White	21
16	The Impact of Catecholamines in Patients with or without Beta‐Blockers on the Ventricular Fibrillation Cycle Length and Ventricular Fibrillation Cycle Length Variability 2005 ·Annals of Noninvasive Electrocardiology ·Bokyung Min, Jeffrey Kluger, James S. Kalus, (unknown), Brian F. McBride, C Michael White	2
17	Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement 2005 ·American Journal of Health-System Pharmacy ·Bokyung Min, Brian F. McBride, (unknown), (unknown), (unknown), Jeffrey Kluger, C Michael White	3
18	Electrocardiographic Effects of an Ephedra‐Free, Multicomponent Weight‐Loss Supplement in Healthy Volunteers 2005 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Bokyung Min, Brian F. McBride, (unknown), (unknown), (unknown), Jeffrey Kluger, C Michael White	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact